No Data
No Data
Benchmark Co. Maintains Repligen(RGEN.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)
J.P. Morgan Sticks to Its Buy Rating for Repligen (RGEN)
Buy Recommendation for Repligen Driven by Strong Performance and Positive Growth Outlook
A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $170 to $225
Repligen's Earnings Call: Growth Amid Challenges